Mumbai: Aurobindo Pharma announced on October 3, 2026, that it has received final approval from the USFDA to manufacture and market Perampanel Tablets in 2 mg, 4 mg, 6 mg, 8 mg, 10 mg, and 12 mg strengths. These tablets are bioequivalent and therapeutically equivalent to Fycompa® Tablets from Catalyst Pharmaceuticals, Inc. Market Opportunity The estimated market size for Perampanel Tablets stood…
India is a land of festivals that mean good food and enjoyment. But they can cause health and digestive troubles. October and November this year have many festivals coming up.
Uncertainty over Kenyas abortion laws is creating difficulties for patients and healthcare providers, prompting calls for clearer rules and better reproductive healthcare.
Anyone with ovaries who lives long enough will experience menopause. While menopause is a natural transition in midlife, it can strongly affect a person's quality of life and their current and future…
